AirSculpt Technologies, Inc. (NASDAQ:AIRS – Get Free Report) CEO Dennis Dean sold 7,719 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $7.53, for a total transaction of $58,124.07. Following the completion of the transaction, the chief executive officer now owns 628,940 shares in the company, valued at $4,735,918.20. This trade represents a 1.21 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Dennis Dean also recently made the following trade(s):
- On Friday, November 15th, Dennis Dean sold 24,510 shares of AirSculpt Technologies stock. The stock was sold at an average price of $6.54, for a total transaction of $160,295.40.
AirSculpt Technologies Stock Performance
AirSculpt Technologies stock traded down $0.45 during midday trading on Friday, hitting $6.51. The stock had a trading volume of 354,838 shares, compared to its average volume of 85,377. The firm’s fifty day moving average is $5.55 and its two-hundred day moving average is $4.75. The company has a market capitalization of $376.80 million, a PE ratio of -46.50 and a beta of 1.57. AirSculpt Technologies, Inc. has a 52-week low of $2.92 and a 52-week high of $9.20. The company has a current ratio of 0.51, a quick ratio of 0.86 and a debt-to-equity ratio of 0.80.
Institutional Investors Weigh In On AirSculpt Technologies
A number of institutional investors have recently added to or reduced their stakes in the stock. SW Investment Management LLC grew its holdings in AirSculpt Technologies by 5.0% during the 2nd quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock valued at $18,000,000 after buying an additional 213,677 shares in the last quarter. Vanguard Group Inc. grew its holdings in AirSculpt Technologies by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 576,038 shares of the company’s stock valued at $3,537,000 after buying an additional 5,606 shares in the last quarter. FourWorld Capital Management LLC purchased a new stake in AirSculpt Technologies during the 1st quarter valued at approximately $557,000. Finally, Barclays PLC grew its holdings in AirSculpt Technologies by 227.0% during the 3rd quarter. Barclays PLC now owns 19,100 shares of the company’s stock valued at $97,000 after buying an additional 13,259 shares in the last quarter. 91.54% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Separately, BTIG Research started coverage on shares of AirSculpt Technologies in a research note on Thursday, October 17th. They issued a “neutral” rating on the stock. Five research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $5.50.
View Our Latest Research Report on AirSculpt Technologies
About AirSculpt Technologies
AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.
Featured Articles
- Five stocks we like better than AirSculpt Technologies
- What is Short Interest? How to Use It
- How Whitestone REIT is Transforming Sunbelt Retail Growth
- What is the Dow Jones Industrial Average (DJIA)?
- Top-Performing Non-Leveraged ETFs This Year
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.